What, exactly, the new $400M offshoot of DaVita and Medtronic aims to do


Both companies contributed $200 million in capital to create Mozarc Medical, a new kidney health tech company.

Previous 40 Under 40: David Younger, A-Alpha Bio
Next Office Depot closes deal to sell South Florida headquarters for $104 million